Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
Philippe M. Loiseau, Kaluvu Balaraman, Gillian Barratt, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2313-2313
Open Access | Times Cited: 21

Showing 21 citing articles:

Recent advances in chemistry and therapeutic potential of functionalized quinoline motifs – a review
Olayinka O. Ajani, King T. Iyaye, Olabisi Theresa Ademosun
RSC Advances (2022) Vol. 12, Iss. 29, pp. 18594-18614
Open Access | Times Cited: 132
Leishmaniasis y su Resistencia a Fármacos: Un Enfoque Bibliométrico
César Aníbal Barzola Gaibor
Estudios y Perspectivas Revista Científica y Académica (2025) Vol. 4, Iss. 4, pp. 2464-2512
Closed Access
The literature of heterocyclic chemistry, part XXII, 2022
Галина А. Газиева, Yu. B. Evdokimenkova, N. O. Soboleva
Advances in heterocyclic chemistry (2025)
Closed Access
Quinine and chloroquine: Potential preclinical candidates for the treatment of tegumentary Leishmaniasis
Norton Rubens Diunior Lucas Pejara Rossi, Saara Neri Fialho, Aurileya de Jesus Gouveia, et al.
Acta Tropica (2024) Vol. 252, pp. 107143-107143
Closed Access | Times Cited: 5
Quinoline Derivatives: Promising Antioxidants with Neuroprotective Potential
Luis Felipe Hernández‐Ayala, Eduardo Gabriel Guzmán‐López, Annia Galano
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1853-1853
Open Access | Times Cited: 13
Recent Advances in Metal Complexes Based on Biomimetic and Biocompatible Organic Ligands against Leishmaniasis Infections: State of the Art and Alternatives
Sandra Jiménez-Falcao, José M. Méndez‐Arriaga
Inorganics (2024) Vol. 12, Iss. 7, pp. 190-190
Open Access | Times Cited: 2
Crystal Structure, Hirshfeld Surface Analysis, and Computational Study of Quinolin-8-yl 4-Chlorobenzoate: Insights from Spectroscopic, Thermal, and Antitumor Properties
Juan‐Carlos Castillo, Diana Becerra, Mario A. Macías
Crystals (2023) Vol. 13, Iss. 4, pp. 694-694
Open Access | Times Cited: 4
Unveiling the crystal structure and quantum properties of 6‑bromo-N-pyridin-4-yl-2-thiophen-2-ylquinoline-4-carboxamide: A promising journey towards predicting its anticancer potential
T.S. Shashidhara, C.S. Navyashree, M.K. Hema, et al.
Journal of Molecular Structure (2023) Vol. 1293, pp. 136266-136266
Closed Access | Times Cited: 3
31st Annual GP2A Medicinal Chemistry Conference
Nicolas Primas, Caroline Castera‐Ducros, Romain Paoli-Lombardo, et al.
Drugs and Drug Candidates (2024) Vol. 3, Iss. 1, pp. 209-243
Open Access
Synthesis, crystal structure, and spectroscopic characterization of a new non-centrosymmetric compound, 1-(2-chloroquinolin-3-yl)-N-(4-fluorobenzyl)methanimine
Maha Hachicha, Rawia Nasri, Mohamed Faouzi Zid, et al.
European Journal of Chemistry (2024) Vol. 15, Iss. 1, pp. 25-30
Open Access
QSAR study of anti -leishmania activity of quinolines, A DFT calculation
Sharieh Hosseini, Zahra mashhadi ali tootonphoroosh
Research Square (Research Square) (2024)
Open Access
4‐Quinolinylhydrazone analogues kill Leishmania (Leishmania) amazonensis by inducing apoptosis and mitochondria‐dependent pathway cell death
Juliana da Trindade Granato, Emerson Teixeira da Silva, Ari Sérgio de Oliveira Lemos, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 5
Closed Access
Visible light–driven organic synthesis under ruthenium (RuII)-complex photocatalysis
Goutam Brahmachari
Elsevier eBooks (2024), pp. 151-219
Closed Access
New Quinoline Derivatives and their Antimicrobial Potential Against Candida Albicans and Staphylococcus Aureus
Nícolas Glanzmann, Ari Sérgio de Oliveira Lemos, Raíssa Soares Meinel, et al.
ChemistrySelect (2024) Vol. 9, Iss. 36
Closed Access
Anti-leishmanial therapies: overcoming current challenges with emerging therapies
Shyam Sundar, Prasoon Madhukar, Rajiv Kumar
Expert Review of Anti-infective Therapy (2024)
Closed Access
The binuclear cyclopalladated complex CP2 is targeting ubiquinol-cytochrome c reductase (Complex III) of Leishmania amazonensis
Ángela María Arenas Velásquez, Irwin A.P. Linares, Lawrence D. Gaspers, et al.
International Journal for Parasitology Drugs and Drug Resistance (2024) Vol. 27, pp. 100574-100574
Open Access
Current state of the art of gold complexes as antileishmanial agents
Catherine Hemmert, Heinz Gornitzka, Céline Deraeve, et al.
Coordination Chemistry Reviews (2024) Vol. 528, pp. 216408-216408
Open Access
Synthesis and Anti-Leishmanial Properties of Quinolones Derived from Zanthosimuline
Gwenaëlle Jézéquel, Laura Nogueira de Faria Cardoso, Florent Olivon, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7892-7892
Open Access | Times Cited: 3
Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs
Roger Espinosa-Sáez, Sara M. Robledo, Tatiana Pineda, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Screening of the antileishmanial and antiplasmodial potential of synthetic 2-arylquinoline analogs
Roger Espinosa-Sáez, Sara M. Robledo, Tatiana Pineda, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Synthesis, Characterization and Biological Evaluation of Novel Isoxazolo [5,4-b] Quinolines as potent Antimicrobial Agents
Varsha Snehi, Devender Pathak
International Journal of Pharmaceutical Sciences and Drug Research (2022), pp. 725-733
Open Access | Times Cited: 2
Page 1

Scroll to top